课题基金 / 基金详情

DEVELOPMENT OF FLURBIPROFEN AS A SELECTIVE PROBE OF CYP2C9

DEVELOPMENT OF FLURBIPROFEN AS A SELECTIVE PROBE OF CYP2C9
氟比洛芬作为 CYP2C9 选择性探针的开发
批准号:
6245702
负责人:
ADEDAYO ADEDOYIN
金额:
$1.76万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-18 至 1997-11-30

项目摘要

项目成果

ADEDAYO ADEDOYIN的其他基金

相似基金

相关文献

中文摘要
翻译
药物代谢是体内参与药物代谢的重要过程 一些化合物的消除和活化 随之而来的毒性。该项目旨在 研究氟比洛芬作为选择性探针的潜在用途 CYP2C9&将其整合到已经开发的 5种药物鸡尾酒。我们的目标是能够广泛使用它 人群研究以评估细胞色素P450 2 C9在致病机制中的作用 疾病的预后。
英文摘要
Drug metabolism is an important process in the body involved in drug elimination as well as in activation of some compounds & the consequential development of toxicities. This project is designed to investigate the potential use of Flubiprofen as a selective probe of CYP2C9 & the possibility of incorporating it into an already developed 5 drug cocktail. The objective is to be able to use it in large population studies to assess the role of CYP2C9 in the pathogenesis or prognosis of diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DISPOSITION OF DAPSONE
SPECIFICITY OF THE ACTIVITIES OF DIFFERENT MODULATING AGENTS
DEVELOPMENT OF FLURBIPROFEN AS A SELECTIVE PROBE OF CYP2C9
SELECTIVE MODULATION OF ESTROGEN METABOLIC PATHWAYS
海外基金